Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study.

Hongli Chen Jingjing Hao Jing Hu Chang Song Yesheng Zhou Miaomiao Li Jin Chen Xiu Liu Dong Wang Xiaoshan Xu Peixian Xin Jiaxin Zhang Lingjie Liao Yi Feng Dan Li Stephen W Pan Yiming Shao Yuhua Ruan Hui Xing

Published in: JMIR public health and surveillance (2023)

The overall prevalence of PDR in China in 2022 was modest. Targeted genotypic PDR testing and medication compliance interventions must be urgently expanded to address PDR among newly diagnosed people living with HIV in China.

Keyphrases

hiv positive
antiretroviral therapy
men who have sex with men
newly diagnosed
south africa
human immunodeficiency virus
hiv infected
hiv testing
healthcare
hepatitis c virus
physical activity
hiv aids
risk factors
clinical trial
emergency department
cancer therapy